Organizational Changes Encouraged for Safer Prescribing

This article originally appeared here.
Share this content:
Organizational Changes Encouraged for Safer Prescribing
Organizational Changes Encouraged for Safer Prescribing

MONDAY, July 17, 2017 (HealthDay News) -- Organizational changes are recommended by primary care physicians to support safer prescribing, according to a study published in the July/August issue of the Annals of Family Medicine.

Katharine A. Wallis, M.B.Ch.B., Ph.D., from the University of Auckland in New Zealand, and colleagues identified potential physician participants using a snowball sampling technique. Emergent themes were identified from 24 semi-structured interventions that were recorded, transcribed, and analyzed.

The researchers note that physicians described swimming against the tide of patient expectations, the culture of prescribing, and organizational constraints. Deprescribing was associated with inherent risks for themselves and patients, and indicated a sense of vulnerability. A sense of duty to do what was right for the patient was the only incentive for deprescribing. Targeted funding for annual medicines review, computer prompts, improved between-prescriber information flow, improved access to expert advice and user-friendly decision support, increased availability of non-pharmaceutical therapies, and enhanced patient engagement in medicines management were recommended organizational changes to support safer prescribing.

"Regulations and policies should be designed to support physicians in practicing according to their professional ethical values," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Even Overdose Doesn't Stop Opioid Prescribing

Even Overdose Doesn't Stop Opioid Prescribing

Few receive medication-assisted treatment after hospital discharge, researchers find

NT-ProBNP-Guided Treatment No Benefit in High-Risk HFrEF

NT-ProBNP-Guided Treatment No Benefit in High-Risk HFrEF

No improvement in clinical outcomes versus usual care in heart failure and reduced ejection fraction

Oral Corticosteroids No Benefit for LRI in Non-Asthmatic Adults

Oral Corticosteroids No Benefit for LRI in Non-Asthmatic ...

No decrease in cough duration, severity for adults without asthma with lower respiratory tract symptom

is free, fast, and customized just for you!

Already a member?

Sign In Now »